ID   NFS1_HUMAN              Reviewed;         457 AA.
AC   Q9Y697; B3KMA5; B4DXK9; E1P5R8; F5GYK5; Q6P0L8; Q9NTZ5; Q9Y481;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 3.
DT   18-JUN-2025, entry version 218.
DE   RecName: Full=Cysteine desulfurase {ECO:0000305};
DE            EC=2.8.1.7 {ECO:0000269|PubMed:16527810, ECO:0000269|PubMed:18650437, ECO:0000269|PubMed:29097656};
DE   Flags: Precursor;
GN   Name=NFS1 {ECO:0000303|PubMed:18650437, ECO:0000312|HGNC:HGNC:15910};
GN   Synonyms=NIFS {ECO:0000303|PubMed:9885568}; ORFNames=HUSSY-08;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CYTOPLASMIC), ALTERNATIVE INITIATION,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9885568; DOI=10.1016/s1097-2765(00)80295-6;
RA   Land T., Rouault T.A.;
RT   "Targeting of a human iron-sulfur cluster assembly enzyme, nifs, to
RT   different subcellular compartments is regulated through alternative AUG
RT   utilization.";
RL   Mol. Cell 2:807-815(1998).
RN   [2]
RP   SEQUENCE REVISION TO 380-402.
RA   Land T., Rouault T.A.;
RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS CYTOPLASMIC AND 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CYTOPLASMIC).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 140-457 (ISOFORM CYTOPLASMIC).
RX   PubMed=11124703;
RX   DOI=10.1002/1097-0061(200101)18:1<69::aid-yea647>3.0.co;2-h;
RA   Stanchi F., Bertocco E., Toppo S., Dioguardi R., Simionati B., Cannata N.,
RA   Zimbello R., Lanfranchi G., Valle G.;
RT   "Characterization of 16 novel human genes showing high similarity to yeast
RT   sequences.";
RL   Yeast 18:69-80(2001).
RN   [8]
RP   INTERACTION WITH ISCU.
RX   PubMed=11060020; DOI=10.1093/emboj/19.21.5692;
RA   Tong W.-H., Rouault T.;
RT   "Distinct iron-sulfur cluster assembly complexes exist in the cytosol and
RT   mitochondria of human cells.";
RL   EMBO J. 19:5692-5700(2000).
RN   [9]
RP   FUNCTION (ISOFORM CYTOPLASMIC), CATALYTIC ACTIVITY (ISOFORM CYTOPLASMIC),
RP   INTERACTION WITH ISCU (ISOFORM CYTOPLASMIC), AND SUBUNIT (ISOFORM
RP   CYTOPLASMIC).
RX   PubMed=16527810; DOI=10.1074/jbc.m600582200;
RA   Li K., Tong W.H., Hughes R.M., Rouault T.A.;
RT   "Roles of the mammalian cytosolic cysteine desulfurase, ISCS, and scaffold
RT   protein, ISCU, in iron-sulfur cluster assembly.";
RL   J. Biol. Chem. 281:12344-12351(2006).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, INTERACTION
RP   WITH LYRM4 AND MOCS3, ACTIVITY REGULATION, PROBABLE ACTIVE SITE, AND
RP   SULFHYDRATION AT CYS-381.
RX   PubMed=18650437; DOI=10.1074/jbc.m804064200;
RA   Marelja Z., Stoecklein W., Nimtz M., Leimkuehler S.;
RT   "A novel role for human Nfs1 in the cytoplasm: Nfs1 acts as a sulfur donor
RT   for MOCS3, a protein involved in molybdenum cofactor biosynthesis.";
RL   J. Biol. Chem. 283:25178-25185(2008).
RN   [11]
RP   INTERACTION WITH LYRM4, AND SUBCELLULAR LOCATION.
RX   PubMed=19454487; DOI=10.1093/hmg/ddp239;
RA   Shi Y., Ghosh M.C., Tong W.H., Rouault T.A.;
RT   "Human ISD11 is essential for both iron-sulfur cluster assembly and
RT   maintenance of normal cellular iron homeostasis.";
RL   Hum. Mol. Genet. 18:3014-3025(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   COMPONENT OF CORE (FE-S) CLUSTER ASSEMBLY COMPLEX.
RX   PubMed=21298097; DOI=10.1371/journal.pone.0016199;
RA   Schmucker S., Martelli A., Colin F., Page A., Wattenhofer-Donze M.,
RA   Reutenauer L., Puccio H.;
RT   "Mammalian frataxin: an essential function for cellular viability through
RT   an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly
RT   complex.";
RL   PLoS ONE 6:e16199-e16199(2011).
RN   [14]
RP   INTERACTION WITH ISCU.
RX   PubMed=23940031; DOI=10.1074/jbc.m113.482042;
RA   Cai K., Frederick R.O., Kim J.H., Reinen N.M., Tonelli M., Markley J.L.;
RT   "Human mitochondrial chaperone (mtHSP70) and cysteine desulfurase (NFS1)
RT   bind preferentially to the disordered conformation, whereas co-chaperone
RT   (HSC20) binds to the structured conformation of the iron-sulfur cluster
RT   scaffold protein (ISCU).";
RL   J. Biol. Chem. 288:28755-28770(2013).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH MOCS3, SUBCELLULAR LOCATION,
RP   PROBABLE ACTIVE SITE, AND SULFHYDRATION AT CYS-381.
RX   PubMed=23593335; DOI=10.1371/journal.pone.0060869;
RA   Marelja Z., Mullick Chowdhury M., Dosche C., Hille C., Baumann O.,
RA   Loehmannsroeben H.G., Leimkuehler S.;
RT   "The L-cysteine desulfurase NFS1 is localized in the cytosol where it
RT   provides the sulfur for molybdenum cofactor biosynthesis in humans.";
RL   PLoS ONE 8:e60869-e60869(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   INTERACTION WITH HSPA9, AND SUBCELLULAR LOCATION.
RX   PubMed=26702583; DOI=10.1016/j.mito.2015.12.005;
RA   Shan Y., Cortopassi G.;
RT   "Mitochondrial Hspa9/Mortalin regulates erythroid differentiation via iron-
RT   sulfur cluster assembly.";
RL   Mitochondrion 26:94-103(2016).
RN   [18]
RP   SUBCELLULAR LOCATION.
RX   PubMed=30817134; DOI=10.1021/acs.biochem.8b01160;
RA   Neukranz Y., Kotter A., Beilschmidt L., Marelja Z., Helm M., Graef R.,
RA   Leimkuehler S.;
RT   "Analysis of the Cellular Roles of MOCS3 Identifies a MOCS3-Independent
RT   Localization of NFS1 at the Tips of the Centrosome.";
RL   Biochemistry 58:1786-1798(2019).
RN   [19]
RP   INTERACTION WITH LYRM4.
RX   PubMed=31664822; DOI=10.1021/acs.biochem.9b00539;
RA   Herrera M.G., Noguera M.E., Sewell K.E., Agudelo Suarez W.A., Capece L.,
RA   Klinke S., Santos J.;
RT   "Structure of the Human ACP-ISD11 Heterodimer.";
RL   Biochemistry 58:4596-4609(2019).
RN   [20] {ECO:0007744|PDB:5WGB, ECO:0007744|PDB:5WKP, ECO:0007744|PDB:5WLW}
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 56-457 IN COMPLEX WITH ZINC ION;
RP   ISCU; LYRM4 AND PYRIDOXAL 5' PHOSPHATE, CATALYTIC ACTIVITY, FUNCTION,
RP   SUBUNIT, INTERACTION WITH ISCU; LYRM4 AND FDX2, PYRIDOXAL 5' PHOSPHATE AT
RP   258, COFACTOR, AND COMPONENT OF CORE (FE-S) CLUSTER ASSEMBLY COMPLEX.
RX   PubMed=29097656; DOI=10.1038/s41467-017-01497-1;
RA   Boniecki M.T., Freibert S.A., Muhlenhoff U., Lill R., Cygler M.;
RT   "Structure and functional dynamics of the mitochondrial Fe/S cluster
RT   synthesis complex.";
RL   Nat. Commun. 8:1287-1287(2017).
RN   [21] {ECO:0007744|PDB:6NZU}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.20 ANGSTROMS) OF 56-457 IN COMPLEX WITH
RP   ISCU; LYRM4; FXN AND PYRIDOXAL 5' PHOSPHATE, SUBUNIT, PYRIDOXAL 5'
RP   PHOSPHATE AT 258, COFACTOR, CATALYTIC ACTIVITY, INTERACTION WITH FXN, AND
RP   COMPONENT OF CORE (FE-S) CLUSTER ASSEMBLY COMPLEX.
RX   PubMed=31101807; DOI=10.1038/s41467-019-09989-y;
RA   Fox N.G., Yu X., Feng X., Bailey H.J., Martelli A., Nabhan J.F.,
RA   Strain-Damerell C., Bulawa C., Yue W.W., Han S.;
RT   "Structure of the human frataxin-bound iron-sulfur cluster assembly complex
RT   provides insight into its activation mechanism.";
RL   Nat. Commun. 10:2210-2210(2019).
RN   [22] {ECO:0007744|PDB:6UXE, ECO:0007744|PDB:6W1D, ECO:0007744|PDB:6WI2, ECO:0007744|PDB:6WIH, ECO:0007744|PDB:7RTK}
RP   X-RAY CRYSTALLOGRAPHY (1.57 ANGSTROMS) OF 56-457 IN COMPLEX WITH ISCU;
RP   LYRM4 AND PYRIDOXAL 5' PHOSPHATE, PYRIDOXAL 5' PHOSPHATE AT 258, COFACTOR,
RP   AND COMPONENT OF THE CYTEINE DESULFURASE COMPLEX.
RX   PubMed=34824239; DOI=10.1038/s41467-021-27122-w;
RA   Freibert S.A., Boniecki M.T., Stuempfig C., Schulz V., Krapoth N.,
RA   Winge D.R., Muehlenhoff U., Stehling O., Cygler M., Lill R.;
RT   "N-terminal tyrosine of ISCU2 triggers [2Fe-2S] cluster synthesis by ISCU2
RT   dimerization.";
RL   Nat. Commun. 12:6902-6902(2021).
RN   [23]
RP   VARIANT COXPD52 GLN-72, INVOLVEMENT IN COXPD52, AND CHARACTERIZATION OF
RP   VARIANT COXPD52 GLN-72.
RX   PubMed=24498631; DOI=10.1002/mgg3.46;
RA   Farhan S.M., Wang J., Robinson J.F., Lahiry P., Siu V.M., Prasad C.,
RA   Kronick J.B., Ramsay D.A., Rupar C.A., Hegele R.A.;
RT   "Exome sequencing identifies NFS1 deficiency in a novel Fe-S cluster
RT   disease, infantile mitochondrial complex II/III deficiency.";
RL   Mol. Genet. Genomic Med. 2:73-80(2014).
RN   [24]
RP   VARIANT COXPD52 GLN-72, AND INVOLVEMENT IN COXPD52.
RX   PubMed=33457206; DOI=10.1016/j.ymgmr.2020.100699;
RG   Regeneron Genetics Center;
RA   Hershkovitz T., Kurolap A., Tal G., Paperna T., Mory A., Staples J.,
RA   Brigatti K.W., Gonzaga-Jauregui C., Dumin E., Saada A., Mandel H.,
RA   Baris Feldman H.;
RT   "A recurring NFS1 pathogenic variant causes a mitochondrial disorder with
RT   variable intra-familial patient outcomes.";
RL   Mol. Genet. Metab. Rep. 26:100699-100699(2021).
CC   -!- FUNCTION: [Isoform Mitochondrial]: Cysteine desulfurase, of the core
CC       iron-sulfur cluster (ISC) assembly complex, that catalyzes the
CC       desulfuration of L-cysteine to L-alanine, as component of the cysteine
CC       desulfurase complex, leading to the formation of a cysteine persulfide
CC       intermediate at the active site cysteine residue and participates in
CC       the [2Fe-2S] clusters assembly on the scaffolding protein ISCU
CC       (PubMed:18650437, PubMed:29097656, PubMed:31101807). The persulfide is
CC       then transferred on the flexible Cys loop from the catalytic site of
CC       NFS1 to the surface of NFS1 (PubMed:29097656). After the NFS1-linked
CC       persulfide sulfur is transferred to one of the conserved Cys residues
CC       of the scaffold, a reaction assisted by FXN (By similarity). The core
CC       iron-sulfur cluster (ISC) assembly complex is involved in the de novo
CC       synthesis of a [2Fe-2S] cluster, the first step of the mitochondrial
CC       iron-sulfur protein biogenesis. This process is initiated by the
CC       cysteine desulfurase complex (NFS1:LYRM4:NDUFAB1) that produces
CC       persulfide which is delivered on the scaffold protein ISCU in a FXN-
CC       dependent manner. Then this complex is stabilized by FDX2 which
CC       provides reducing equivalents to accomplish the [2Fe-2S] cluster
CC       assembly. Finally, the [2Fe-2S] cluster is transferred from ISCU to
CC       chaperone proteins, including HSCB, HSPA9 and GLRX5 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9H1K1, ECO:0000250|UniProtKB:Q9Z1J3,
CC       ECO:0000269|PubMed:18650437, ECO:0000269|PubMed:29097656,
CC       ECO:0000269|PubMed:31101807}.
CC   -!- FUNCTION: [Isoform Cytoplasmic]: May catalyze the desulfuration of L-
CC       cysteine to L-alanine as component of the cysteine desulfurase complex
CC       (NFS1:LYRM4), leading to the formation of a cysteine persulfide
CC       intermediate (PubMed:16527810, PubMed:18650437). Acts as a sulfur donor
CC       for MOCS3 by transferring the sulfur of the cysteine persulfide
CC       intermediate on MOCS3 (PubMed:18650437, PubMed:23593335).
CC       {ECO:0000269|PubMed:16527810, ECO:0000269|PubMed:18650437,
CC       ECO:0000269|PubMed:23593335}.
CC   -!- CATALYTIC ACTIVITY: [Isoform Mitochondrial]:
CC       Reaction=(sulfur carrier)-H + L-cysteine = (sulfur carrier)-SH + L-
CC         alanine; Xref=Rhea:RHEA:43892, Rhea:RHEA-COMP:14737, Rhea:RHEA-
CC         COMP:14739, ChEBI:CHEBI:29917, ChEBI:CHEBI:35235, ChEBI:CHEBI:57972,
CC         ChEBI:CHEBI:64428; EC=2.8.1.7; Evidence={ECO:0000269|PubMed:18650437,
CC         ECO:0000269|PubMed:29097656, ECO:0000269|PubMed:31101807};
CC   -!- CATALYTIC ACTIVITY: [Isoform Cytoplasmic]:
CC       Reaction=(sulfur carrier)-H + L-cysteine = (sulfur carrier)-SH + L-
CC         alanine; Xref=Rhea:RHEA:43892, Rhea:RHEA-COMP:14737, Rhea:RHEA-
CC         COMP:14739, ChEBI:CHEBI:29917, ChEBI:CHEBI:35235, ChEBI:CHEBI:57972,
CC         ChEBI:CHEBI:64428; EC=2.8.1.7; Evidence={ECO:0000269|PubMed:16527810,
CC         ECO:0000305|PubMed:18650437};
CC   -!- CATALYTIC ACTIVITY: [Isoform Cytoplasmic]:
CC       Reaction=L-cysteinyl-[cysteine desulfurase] + L-cysteine = S-sulfanyl-
CC         L-cysteinyl-[cysteine desulfurase] + L-alanine; Xref=Rhea:RHEA:17457,
CC         Rhea:RHEA-COMP:12157, Rhea:RHEA-COMP:12158, ChEBI:CHEBI:29950,
CC         ChEBI:CHEBI:35235, ChEBI:CHEBI:57972, ChEBI:CHEBI:61963;
CC         Evidence={ECO:0000269|PubMed:18650437, ECO:0000269|PubMed:23593335};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:29097656, ECO:0000269|PubMed:31101807,
CC         ECO:0000269|PubMed:34824239};
CC   -!- ACTIVITY REGULATION: Active only in complex with LYRM4.
CC       {ECO:0000269|PubMed:18650437}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=434.75 uM for L-cysteine {ECO:0000269|PubMed:18650437};
CC         Note=Kinetic parameter was determined for the protein lacking the 55
CC         N-terminal amino acids and in a complex with LYRM4.
CC         {ECO:0000269|PubMed:18650437};
CC       pH dependence:
CC         Optimum pH is 8. {ECO:0000269|PubMed:18650437};
CC       Temperature dependence:
CC         Optimum temperature is 46 degrees Celsius.
CC         {ECO:0000305|PubMed:18650437};
CC   -!- SUBUNIT: [Isoform Mitochondrial]: Homodimer (PubMed:29097656,
CC       PubMed:31101807). Component of the mitochondrial core iron-sulfur
CC       cluster (ISC) complex composed of NFS1, LYRM4, NDUFAB1, ISCU, FXN, and
CC       FDX2; this complex is a heterohexamer containing two copies of each
CC       monomer (Probable). Component of cyteine desulfurase complex composed
CC       of NFS1, LYRM4 and NDUFAB1; this complex contributes to the activation
CC       of cysteine desulfurase activity and NFS1 stabilization
CC       (PubMed:31664822, PubMed:34824239). Interacts (homodimer form) with
CC       ISCU (D-state); each monomer interacts with the C-terminal regions of
CC       each NFS1 monomer (PubMed:11060020, PubMed:23940031, PubMed:29097656).
CC       Interacts with HSPA9 (PubMed:26702583). Interacts (via homodimer form)
CC       with FDX2 (PubMed:29097656). Interacts (via homodimer form) with FXN
CC       (PubMed:31101807). Interacts with LYRM4 (PubMed:19454487,
CC       PubMed:29097656). Component of a complex composed of FXN, NFS1, LYRM4
CC       and ISCU (By similarity). {ECO:0000250|UniProtKB:Q9Z1J3,
CC       ECO:0000269|PubMed:11060020, ECO:0000269|PubMed:19454487,
CC       ECO:0000269|PubMed:23940031, ECO:0000269|PubMed:26702583,
CC       ECO:0000269|PubMed:29097656, ECO:0000269|PubMed:31101807,
CC       ECO:0000269|PubMed:31664822, ECO:0000269|PubMed:34824239,
CC       ECO:0000305|PubMed:21298097, ECO:0000305|PubMed:29097656,
CC       ECO:0000305|PubMed:31101807}.
CC   -!- SUBUNIT: [Isoform Cytoplasmic]: Monomer (PubMed:16527810). Homodimer
CC       (PubMed:16527810, PubMed:18650437, PubMed:23593335). Oligomer
CC       (PubMed:18650437). Interacts with ISCU (PubMed:16527810). Component of
CC       the cysteine desulfurase complex composed of NFS1 and LYRM4; this
CC       complex contributes to the activation of cysteine desulfurase activity
CC       (PubMed:18650437). Interacts with MOCS3 (PubMed:18650437,
CC       PubMed:23593335). {ECO:0000269|PubMed:16527810,
CC       ECO:0000269|PubMed:18650437, ECO:0000269|PubMed:23593335}.
CC   -!- INTERACTION:
CC       Q9Y697; Q9NZJ6: COQ3; NbExp=3; IntAct=EBI-1751791, EBI-10897372;
CC       Q9Y697; Q9HD34: LYRM4; NbExp=10; IntAct=EBI-1751791, EBI-3920810;
CC   -!- SUBCELLULAR LOCATION: [Isoform Mitochondrial]: Mitochondrion
CC       {ECO:0000269|PubMed:19454487, ECO:0000269|PubMed:23593335,
CC       ECO:0000269|PubMed:26702583, ECO:0000269|PubMed:30817134,
CC       ECO:0000269|PubMed:9885568}.
CC   -!- SUBCELLULAR LOCATION: [Isoform Cytoplasmic]: Cytoplasm
CC       {ECO:0000269|PubMed:23593335, ECO:0000269|PubMed:30817134,
CC       ECO:0000269|PubMed:9885568}. Nucleus {ECO:0000269|PubMed:19454487,
CC       ECO:0000269|PubMed:23593335, ECO:0000269|PubMed:9885568}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:30817134}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=3;
CC         Comment=Individual cells may vary AUG utilization in accordance with
CC         changes in metabolic status, the cytosolic pH being a strong
CC         determinant of this modulation.;
CC       Name=Mitochondrial;
CC         IsoId=Q9Y697-1; Sequence=Displayed;
CC       Name=Cytoplasmic;
CC         IsoId=Q9Y697-2; Sequence=VSP_018646;
CC       Name=3;
CC         IsoId=Q9Y697-3; Sequence=VSP_045860;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in heart and skeletal
CC       muscle. Also found in brain, liver and pancreas.
CC       {ECO:0000269|PubMed:9885568}.
CC   -!- PTM: N-gluconoylated. {ECO:0000250|UniProtKB:Q9Z1J3}.
CC   -!- PTM: Cysteine persulfide intermediate is reduced by thiol-containing
CC       molecules like glutathione and L-cysteine. Persulfide reduction is a
CC       rate-limiting step of cysteine desulfurase catalytic cycle.
CC       {ECO:0000250|UniProtKB:Q9Z1J3}.
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 52 (COXPD52)
CC       [MIM:619386]: An autosomal recessive mitochondrial disorder with onset
CC       in infancy, characterized by lactic acidemia, hypotonia, respiratory
CC       chain complex II and III deficiency, multisystem organ failure and
CC       abnormal mitochondria. {ECO:0000269|PubMed:24498631,
CC       ECO:0000269|PubMed:33457206}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-V pyridoxal-phosphate-dependent
CC       aminotransferase family. NifS/IscS subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF097025; AAD09187.2; -; mRNA.
DR   EMBL; AK001470; BAG50917.1; -; mRNA.
DR   EMBL; AK302023; BAG63421.1; -; mRNA.
DR   EMBL; AL109827; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357374; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW76170.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW76172.1; -; Genomic_DNA.
DR   EMBL; BC065560; AAH65560.1; -; mRNA.
DR   EMBL; AJ010952; CAA09424.1; -; mRNA.
DR   CCDS; CCDS13262.1; -. [Q9Y697-1]
DR   CCDS; CCDS56185.1; -. [Q9Y697-3]
DR   RefSeq; NP_001185918.1; NM_001198989.2. [Q9Y697-3]
DR   RefSeq; NP_066923.3; NM_021100.4. [Q9Y697-1]
DR   PDB; 5KZ5; EM; 14.30 A; 1/2/3/4/M/N/O/P/Q/R/S/T=67-457.
DR   PDB; 5USR; X-ray; 3.09 A; A/C/E/G=56-457.
DR   PDB; 5WGB; X-ray; 2.75 A; A=56-457.
DR   PDB; 5WKP; X-ray; 3.15 A; A/E=56-457.
DR   PDB; 5WLW; X-ray; 3.32 A; A/E=56-457.
DR   PDB; 6NZU; EM; 3.20 A; A/E=55-457.
DR   PDB; 6UXE; X-ray; 1.57 A; A=56-457.
DR   PDB; 6W1D; X-ray; 1.79 A; A=56-457.
DR   PDB; 6WI2; X-ray; 1.95 A; A=56-457.
DR   PDB; 6WIH; X-ray; 1.90 A; A=56-457.
DR   PDB; 7RTK; X-ray; 2.50 A; A=56-457.
DR   PDB; 8PK8; EM; 2.49 A; A=56-457.
DR   PDB; 8PK9; EM; 2.58 A; A=56-457.
DR   PDB; 8PKA; EM; 2.75 A; A=56-457.
DR   PDB; 8RMC; EM; 2.26 A; A/E=56-457.
DR   PDB; 8RMD; EM; 2.52 A; A/E=56-457.
DR   PDB; 8RME; EM; 2.49 A; A/E=56-457.
DR   PDB; 8RMF; EM; 2.33 A; A/E=56-457.
DR   PDB; 8RMG; EM; 2.46 A; A/E=56-457.
DR   PDB; 8TVT; X-ray; 2.00 A; A=56-454.
DR   PDBsum; 5KZ5; -.
DR   PDBsum; 5USR; -.
DR   PDBsum; 5WGB; -.
DR   PDBsum; 5WKP; -.
DR   PDBsum; 5WLW; -.
DR   PDBsum; 6NZU; -.
DR   PDBsum; 6UXE; -.
DR   PDBsum; 6W1D; -.
DR   PDBsum; 6WI2; -.
DR   PDBsum; 6WIH; -.
DR   PDBsum; 7RTK; -.
DR   PDBsum; 8PK8; -.
DR   PDBsum; 8PK9; -.
DR   PDBsum; 8PKA; -.
DR   PDBsum; 8RMC; -.
DR   PDBsum; 8RMD; -.
DR   PDBsum; 8RME; -.
DR   PDBsum; 8RMF; -.
DR   PDBsum; 8RMG; -.
DR   PDBsum; 8TVT; -.
DR   AlphaFoldDB; Q9Y697; -.
DR   EMDB; EMD-0560; -.
DR   EMDB; EMD-17732; -.
DR   EMDB; EMD-17733; -.
DR   EMDB; EMD-17734; -.
DR   EMDB; EMD-19356; -.
DR   EMDB; EMD-19357; -.
DR   EMDB; EMD-19359; -.
DR   EMDB; EMD-19360; -.
DR   EMDB; EMD-19361; -.
DR   EMDB; EMD-8301; -.
DR   SASBDB; Q9Y697; -.
DR   SMR; Q9Y697; -.
DR   BioGRID; 114516; 153.
DR   ComplexPortal; CPX-5641; Mitochondrial NIAUFX iron-sulfur cluster assembly complex.
DR   CORUM; Q9Y697; -.
DR   FunCoup; Q9Y697; 3144.
DR   IntAct; Q9Y697; 62.
DR   MINT; Q9Y697; -.
DR   STRING; 9606.ENSP00000363205; -.
DR   DrugBank; DB00160; Alanine.
DR   DrugBank; DB00151; Cysteine.
DR   DrugBank; DB00114; Pyridoxal phosphate.
DR   GlyGen; Q9Y697; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9Y697; -.
DR   PhosphoSitePlus; Q9Y697; -.
DR   SwissPalm; Q9Y697; -.
DR   BioMuta; NFS1; -.
DR   DMDM; 62512153; -.
DR   jPOST; Q9Y697; -.
DR   MassIVE; Q9Y697; -.
DR   PaxDb; 9606-ENSP00000363205; -.
DR   PeptideAtlas; Q9Y697; -.
DR   ProteomicsDB; 24766; -.
DR   ProteomicsDB; 86633; -. [Q9Y697-1]
DR   ProteomicsDB; 86634; -. [Q9Y697-2]
DR   Pumba; Q9Y697; -.
DR   Antibodypedia; 35035; 234 antibodies from 26 providers.
DR   DNASU; 9054; -.
DR   Ensembl; ENST00000374085.5; ENSP00000363198.1; ENSG00000244005.13. [Q9Y697-2]
DR   Ensembl; ENST00000374092.9; ENSP00000363205.3; ENSG00000244005.13. [Q9Y697-1]
DR   Ensembl; ENST00000397425.5; ENSP00000380570.1; ENSG00000244005.13. [Q9Y697-2]
DR   Ensembl; ENST00000541387.5; ENSP00000440897.1; ENSG00000244005.13. [Q9Y697-3]
DR   GeneID; 9054; -.
DR   KEGG; hsa:9054; -.
DR   MANE-Select; ENST00000374092.9; ENSP00000363205.3; NM_021100.5; NP_066923.3.
DR   UCSC; uc002xdt.3; human. [Q9Y697-1]
DR   AGR; HGNC:15910; -.
DR   CTD; 9054; -.
DR   DisGeNET; 9054; -.
DR   GeneCards; NFS1; -.
DR   HGNC; HGNC:15910; NFS1.
DR   HPA; ENSG00000244005; Low tissue specificity.
DR   MalaCards; NFS1; -.
DR   MIM; 603485; gene.
DR   MIM; 619386; phenotype.
DR   OpenTargets; ENSG00000244005; -.
DR   Orphanet; 397593; Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency.
DR   VEuPathDB; HostDB:ENSG00000244005; -.
DR   eggNOG; KOG1549; Eukaryota.
DR   GeneTree; ENSGT00940000155740; -.
DR   HOGENOM; CLU_003433_0_2_1; -.
DR   InParanoid; Q9Y697; -.
DR   OMA; KGLYWAR; -.
DR   OrthoDB; 10250117at2759; -.
DR   PAN-GO; Q9Y697; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9Y697; -.
DR   BioCyc; MetaCyc:HS01304-MONOMER; -.
DR   BRENDA; 2.8.1.7; 2681.
DR   PathwayCommons; Q9Y697; -.
DR   Reactome; R-HSA-1362409; Mitochondrial iron-sulfur cluster biogenesis. [Q9Y697-1]
DR   Reactome; R-HSA-947581; Molybdenum cofactor biosynthesis. [Q9Y697-2]
DR   Reactome; R-HSA-9854311; Maturation of TCA enzymes and regulation of TCA cycle. [Q9Y697-1]
DR   Reactome; R-HSA-9865881; Complex III assembly. [Q9Y697-1]
DR   SignaLink; Q9Y697; -.
DR   SIGNOR; Q9Y697; -.
DR   BioGRID-ORCS; 9054; 699 hits in 1138 CRISPR screens.
DR   ChiTaRS; NFS1; human.
DR   GeneWiki; NFS1; -.
DR   GenomeRNAi; 9054; -.
DR   Pharos; Q9Y697; Tbio.
DR   PRO; PR:Q9Y697; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9Y697; protein.
DR   Bgee; ENSG00000244005; Expressed in right adrenal gland cortex and 180 other cell types or tissues.
DR   ExpressionAtlas; Q9Y697; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:1990229; C:iron-sulfur cluster assembly complex; NAS:ComplexPortal.
DR   GO; GO:0099128; C:mitochondrial [2Fe-2S] assembly complex; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:HGNC-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031071; F:cysteine desulfurase activity; IDA:UniProtKB.
DR   GO; GO:0051536; F:iron-sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0097163; F:sulfur carrier activity; IDA:FlyBase.
DR   GO; GO:0044571; P:[2Fe-2S] cluster assembly; IDA:UniProtKB.
DR   GO; GO:0044572; P:[4Fe-4S] cluster assembly; IDA:UniProtKB.
DR   GO; GO:0016226; P:iron-sulfur cluster assembly; IDA:HGNC-UCL.
DR   GO; GO:0006777; P:Mo-molybdopterin cofactor biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0043545; P:molybdopterin cofactor metabolic process; IDA:UniProtKB.
DR   FunFam; 3.40.640.10:FF:000003; Cysteine desulfurase IscS; 1.
DR   FunFam; 3.90.1150.10:FF:000002; Cysteine desulfurase IscS; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   HAMAP; MF_00331; Cys_desulf_IscS; 1.
DR   InterPro; IPR000192; Aminotrans_V_dom.
DR   InterPro; IPR020578; Aminotrans_V_PyrdxlP_BS.
DR   InterPro; IPR010240; Cys_deSase_IscS.
DR   InterPro; IPR016454; Cysteine_dSase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   NCBIfam; TIGR02006; IscS; 1.
DR   NCBIfam; NF002806; PRK02948.1; 1.
DR   NCBIfam; NF010611; PRK14012.1; 1.
DR   PANTHER; PTHR11601:SF34; CYSTEINE DESULFURASE; 1.
DR   PANTHER; PTHR11601; CYSTEINE DESULFURYLASE FAMILY MEMBER; 1.
DR   Pfam; PF00266; Aminotran_5; 1.
DR   PIRSF; PIRSF005572; NifS; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
DR   PROSITE; PS00595; AA_TRANSFER_CLASS_5; 1.
DR   neXtProt; NX_Q9Y697; -.
DR   PharmGKB; PA31607; -.
DR   TreeFam; TF105658; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Alternative splicing; Cytoplasm;
KW   Cytoskeleton; Disease variant; Iron; Iron-sulfur; Metal-binding;
KW   Mitochondrion; Molybdenum cofactor biosynthesis; Nucleus;
KW   Primary mitochondrial disease; Proteomics identification;
KW   Pyridoxal phosphate; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT         1..?
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           ?..457
FT                   /note="Cysteine desulfurase"
FT                   /id="PRO_0000001292"
FT   ACT_SITE        381
FT                   /note="Cysteine persulfide intermediate"
FT                   /evidence="ECO:0000305|PubMed:18650437,
FT                   ECO:0000305|PubMed:23593335"
FT   BINDING         127
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0000269|PubMed:34824239, ECO:0007744|PDB:5WKP,
FT                   ECO:0007744|PDB:5WLW, ECO:0007744|PDB:6UXE,
FT                   ECO:0007744|PDB:6W1D, ECO:0007744|PDB:6WI2,
FT                   ECO:0007744|PDB:6WIH, ECO:0007744|PDB:7RTK"
FT   BINDING         128
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0000269|PubMed:31101807, ECO:0000269|PubMed:34824239,
FT                   ECO:0007744|PDB:5WKP, ECO:0007744|PDB:5WLW,
FT                   ECO:0007744|PDB:6NZU, ECO:0007744|PDB:6UXE,
FT                   ECO:0007744|PDB:6W1D, ECO:0007744|PDB:6WI2,
FT                   ECO:0007744|PDB:6WIH, ECO:0007744|PDB:7RTK"
FT   BINDING         235
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0000269|PubMed:31101807, ECO:0000269|PubMed:34824239,
FT                   ECO:0007744|PDB:5WKP, ECO:0007744|PDB:5WLW,
FT                   ECO:0007744|PDB:6NZU, ECO:0007744|PDB:6UXE,
FT                   ECO:0007744|PDB:6W1D, ECO:0007744|PDB:6WI2,
FT                   ECO:0007744|PDB:6WIH, ECO:0007744|PDB:7RTK"
FT   BINDING         255
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0000269|PubMed:31101807, ECO:0000269|PubMed:34824239,
FT                   ECO:0007744|PDB:5WKP, ECO:0007744|PDB:5WLW,
FT                   ECO:0007744|PDB:6NZU, ECO:0007744|PDB:6UXE,
FT                   ECO:0007744|PDB:6W1D, ECO:0007744|PDB:6WI2,
FT                   ECO:0007744|PDB:6WIH, ECO:0007744|PDB:7RTK"
FT   BINDING         257
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0000269|PubMed:31101807, ECO:0000269|PubMed:34824239,
FT                   ECO:0007744|PDB:5WKP, ECO:0007744|PDB:5WLW,
FT                   ECO:0007744|PDB:6NZU, ECO:0007744|PDB:6UXE,
FT                   ECO:0007744|PDB:6W1D, ECO:0007744|PDB:6WI2,
FT                   ECO:0007744|PDB:6WIH, ECO:0007744|PDB:7RTK"
FT   BINDING         295
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0000269|PubMed:31101807, ECO:0007744|PDB:5WKP,
FT                   ECO:0007744|PDB:5WLW, ECO:0007744|PDB:6NZU"
FT   BINDING         381
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_note="ligand shared with ISCU"
FT                   /note="via persulfide group"
FT                   /evidence="ECO:0000250|UniProtKB:O29689"
FT   BINDING         381
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="ligand shared with ISCU (isoform 2)"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0007744|PDB:5WLW"
FT   MOD_RES         258
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000269|PubMed:29097656,
FT                   ECO:0000269|PubMed:31101807, ECO:0000269|PubMed:34824239,
FT                   ECO:0007744|PDB:5WKP, ECO:0007744|PDB:5WLW,
FT                   ECO:0007744|PDB:6NZU, ECO:0007744|PDB:6UXE,
FT                   ECO:0007744|PDB:6W1D, ECO:0007744|PDB:6WI2,
FT                   ECO:0007744|PDB:6WIH, ECO:0007744|PDB:7RTK"
FT   MOD_RES         381
FT                   /note="Cysteine persulfide"
FT                   /evidence="ECO:0000305|PubMed:18650437,
FT                   ECO:0000305|PubMed:23593335"
FT   VAR_SEQ         1..60
FT                   /note="Missing (in isoform Cytoplasmic)"
FT                   /evidence="ECO:0000303|PubMed:11124703,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9885568"
FT                   /id="VSP_018646"
FT   VAR_SEQ         136..186
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045860"
FT   VARIANT         72
FT                   /note="R -> Q (in COXPD52; decreased protein expression in
FT                   homozygous patient cells; dbSNP:rs200592030)"
FT                   /evidence="ECO:0000269|PubMed:24498631,
FT                   ECO:0000269|PubMed:33457206"
FT                   /id="VAR_085966"
FT   CONFLICT        5
FT                   /note="A -> V (in Ref. 1; AAD09187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        47
FT                   /note="A -> T (in Ref. 1; AAD09187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        197
FT                   /note="T -> A (in Ref. 3; BAG63421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        412
FT                   /note="R -> A (in Ref. 1; AAD09187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        431
FT                   /note="K -> N (in Ref. 1; AAD09187)"
FT                   /evidence="ECO:0000305"
FT   TURN            63..65
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           71..82
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           94..114
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           118..120
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          121..125
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           127..141
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            142..145
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          148..152
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           157..168
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          172..176
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           186..192
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          197..201
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            207..209
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           215..224
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          228..232
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            234..239
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            244..248
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          250..255
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           256..258
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          266..270
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            272..275
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   TURN            287..291
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           298..336
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          337..344
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           346..348
FT                   /evidence="ECO:0007829|PDB:7RTK"
FT   STRAND          353..358
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           363..369
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          376..378
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           380..382
FT                   /evidence="ECO:0007829|PDB:6WIH"
FT   TURN            384..386
FT                   /evidence="ECO:0007829|PDB:6WIH"
FT   HELIX           390..394
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           399..402
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   STRAND          405..409
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           416..435
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           438..444
FT                   /evidence="ECO:0007829|PDB:6UXE"
FT   HELIX           449..451
FT                   /evidence="ECO:0007829|PDB:6UXE"
SQ   SEQUENCE   457 AA;  50196 MW;  FDE76177DB6E751B CRC64;
     MLLRAAWRRA AVAVTAAPGP KPAAPTRGLR LRVGDRAPQS AVPADTAAAP EVGPVLRPLY
     MDVQATTPLD PRVLDAMLPY LINYYGNPHS RTHAYGWESE AAMERARQQV ASLIGADPRE
     IIFTSGATES NNIAIKGVAR FYRSRKKHLI TTQTEHKCVL DSCRSLEAEG FQVTYLPVQK
     SGIIDLKELE AAIQPDTSLV SVMTVNNEIG VKQPIAEIGR ICSSRKVYFH TDAAQAVGKI
     PLDVNDMKID LMSISGHKIY GPKGVGAIYI RRRPRVRVEA LQSGGGQERG MRSGTVPTPL
     VVGLGAACEV AQQEMEYDHK RISKLSERLI QNIMKSLPDV VMNGDPKHHY PGCINLSFAY
     VEGESLLMAL KDVALSSGSA CTSASLEPSY VLRAIGTDED LAHSSIRFGI GRFTTEEEVD
     YTVEKCIQHV KRLREMSPLW EMVQDGIDLK SIKWTQH
//
